Celyad VP On IP Issues, Development Timelines For CAR-T Therapies

 
• By Lucie Ellis-Taitt
  
Video interview
Celyad's George Rawadi talks to Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business